Jounce Therapeutics (NASDAQ:JNCE) reported its Q4 earnings results on Wednesday, March 2, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Jounce Therapeutics missed estimated earnings by 84.37%, reporting an EPS of $-0.59 versus an estimate of $-0.32.
Revenue was up $62.34 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 4.37% drop in the share price the next day.
Here's a look at Jounce Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.36 | -0.41 | 0.22 |
| EPS Actual | -0.59 | -0.08 | -0.58 | 0.86 |
| Revenue Estimate | 6.48M | 8.18M | 11.81M | 39.27M |
| Revenue Actual | 0 | 25.37M | 1.54M | 62.34M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
